Australia markets closed

Medifast, Inc. (MED)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
35.51+1.80 (+5.34%)
At close: 04:00PM EDT
29.55 -5.96 (-16.78%)
Pre-market: 07:16AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 388.38M
Enterprise value 260.35M
Trailing P/E 3.90
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.36
Price/book (mrq)1.93
Enterprise value/revenue 0.24
Enterprise value/EBITDA 1.87

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-59.72%
S&P500 52-week change 324.19%
52-week high 3109.52
52-week low 330.95
50-day moving average 336.46
200-day moving average 364.43

Share statistics

Avg vol (3-month) 3392.46k
Avg vol (10-day) 3350k
Shares outstanding 510.94M
Implied shares outstanding 610.94M
Float 89.95M
% held by insiders 12.70%
% held by institutions 196.85%
Shares short (15 Apr 2024) 42.99M
Short ratio (15 Apr 2024) 46.79
Short % of float (15 Apr 2024) 441.67%
Short % of shares outstanding (15 Apr 2024) 427.43%
Shares short (prior month 15 Mar 2024) 42.05M

Dividends & splits

Forward annual dividend rate 46.6
Forward annual dividend yield 418.59%
Trailing annual dividend rate 33.30
Trailing annual dividend yield 39.79%
5-year average dividend yield 44.51
Payout ratio 454.40%
Dividend date 307 Nov 2023
Ex-dividend date 418 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.55%
Operating margin (ttm)4.54%

Management effectiveness

Return on assets (ttm)16.18%
Return on equity (ttm)35.49%

Income statement

Revenue (ttm)897.81M
Revenue per share (ttm)82.40
Quarterly revenue growth (yoy)-49.90%
Gross profit (ttm)N/A
EBITDA 94.24M
Net income avi to common (ttm)67.76M
Diluted EPS (ttm)9.10
Quarterly earnings growth (yoy)-79.20%

Balance sheet

Total cash (mrq)156.43M
Total cash per share (mrq)14.3
Total debt (mrq)20.57M
Total debt/equity (mrq)9.75%
Current ratio (mrq)2.85
Book value per share (mrq)19.29

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A